Sarah L. Chamlin MD
Professor of Pediatrics and Dermatology, Northwestern University Feinberg School of Medicine; Attending Physician, the Ann and Robert H. Lurie Children’s Hospital of Chicago, specializing in Pediatric Dermatology, Chicago, IllinoisSarah L. Chamlin, MD, is a Professor of Pediatrics and Dermatology at Northwestern University Feinberg School of Medicine and an Attending Physician at Lurie Children’s Hospital, specializing in pediatric dermatology. Her clinical interests include hemangiomas and other vascular lesions, hair and nails, and general pediatric dermatology. Her research interests include quality-of-life measurement in children and teens with skin disease and hemangiomas. She is an active member of the Hemangioma Investigator Group.
Disclosures
Sarah L Chamlin, MD, has served as a consultant to Regeneron and Sanofi.
Recent Contributions to PracticeUpdate:
- Overall Burden of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis
- Transient Gross Motor Delay Reported With Oral Propranolol for Infantile Hemangioma
- Topical 1% Propranolol Ointment With Occlusion in Treatment of Pyogenic Granulomas
- Laboratory Monitoring During Systemic Terbinafine Therapy May Not Be Necessary in Children With Onychomycosis
- 2017 Top Stories in Dermatology: Peanut Allergy Prevention: A Practice-Changer for Pediatric Dermatology
- Screening for Thyroid Dysfunction Is Recommended in Select Children With Alopecia Areata
- Long-Term Safety of Crisaborole Ointment 2% for Mild to Moderate Atopic Dermatitis
- Safety and Efficacy of Topical Timolol Treatment of Infantile Hemangioma
- Epidemiology and Predisposing Factors for Erythema Toxicum Neonatorum and Transient Neonatal Pustular Melanosis
- Long-Term Treatment of Cutaneous Manifestations of Tuberous Sclerosis Complex With Topical 1% Sirolimus Cream